Synergene Therapeutics Inc
CAGE Code: 43DC1
NCAGE Code: 43DC1
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 072898005
Summary
Synergene Therapeutics Inc is an Active Commercial Supplier with the Cage Code 43DC1 and is tracked by Dun & Bradstreet under DUNS Number 072898005..
Address
1216 River Bay Rd
Annapolis MD 21409-4916
United States
Points of Contact
- Telephone:
- 3013772108
- Fax:
- 3012993224
Related Information
People who viewed this 'CAGE Code' also viewed...
Abbott Laboratories Abbott B Dalton Bookseller No 469 Bay Technical Associates Inc Tronex Corp Columbia Construction Co Inc Dunton Contracting Inc Jasar Inc Acetrain Inc Unc Inc Giannotti And Associates Of Texas Litton Co Northrop Grumman Corp Graphic Sales Associates C And P Telephone Co Of Maryland Ocean Systems Research Columbia Research Corp Instructional Resources Corp Brown Croft Frazier P A Ori Inc Forensic Technologies Intl Corp
Frequently Asked Questions (FAQ) for CAGE 43DC1
- What is CAGE Code 43DC1?
- 43DC1 is the unique identifier used by NATO Organizations to reference the physical entity known as Synergene Therapeutics Inc located at 1216 River Bay Rd, Annapolis MD 21409-4916, United States.
- Who is CAGE Code 43DC1?
- 43DC1 refers to Synergene Therapeutics Inc located at 1216 River Bay Rd, Annapolis MD 21409-4916, United States.
- Where is CAGE Code 43DC1 Located?
- CAGE Code 43DC1 is located in Annapolis, MD, USA.
Contracting History for CAGE 43DC1 Most Recent 25 Records
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 5 Jul 2023
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $5,259,000.10
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 3 Jun 2021
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $3,151,240.70
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 15 May 2023
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $5,259,000.10
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- 31 Mar 2021
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $3,151,240.70
- Department Of Defense (Dod)
- HDTRA120C0045
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier. (Option Period 1)
- 6 Jul 2023
- Application Of A Nanocomplex Technology To The Active Permeation Of The Blood Brain Barrier. (Option Period 1)
- Defense Threat Reduction Agency
- Department Of Defense (Dod)
- $5,259,000.10
- Department Of Defense (Dod)